Yihao Mao

602 total citations
25 papers, 396 citations indexed

About

Yihao Mao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yihao Mao has authored 25 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Yihao Mao's work include Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (5 papers) and Ferroptosis and cancer prognosis (5 papers). Yihao Mao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (5 papers) and Ferroptosis and cancer prognosis (5 papers). Yihao Mao collaborates with scholars based in China, United States and Spain. Yihao Mao's co-authors include Guodong He, Qingyang Feng, Meiling Ji, Dexiang Zhu, Jianmin Xu, Wenju Chang, Peng Zheng, Ye Wei, Yuqiu Xu and Li Ren and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yihao Mao

24 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yihao Mao China 10 196 143 141 126 89 25 396
Jun Osugi Japan 11 209 1.1× 164 1.1× 131 0.9× 104 0.8× 110 1.2× 31 412
Xiying Shao China 11 184 0.9× 172 1.2× 108 0.8× 85 0.7× 189 2.1× 60 462
Teming Zhang China 6 160 0.8× 135 0.9× 110 0.8× 114 0.9× 89 1.0× 10 324
Helen Thut Switzerland 5 283 1.4× 203 1.4× 291 2.1× 172 1.4× 112 1.3× 7 582
Dagui Lin China 8 252 1.3× 130 0.9× 112 0.8× 203 1.6× 126 1.4× 18 428
Louqian Zhang China 11 147 0.8× 149 1.0× 106 0.8× 139 1.1× 53 0.6× 23 406
Zhengchun Kang China 6 176 0.9× 133 0.9× 163 1.2× 109 0.9× 95 1.1× 11 358
Tiepeng Li China 11 219 1.1× 149 1.0× 129 0.9× 55 0.4× 85 1.0× 37 428
Zaoke He China 7 299 1.5× 197 1.4× 150 1.1× 199 1.6× 202 2.3× 8 545
Nivedita Chowdhury United States 6 200 1.0× 254 1.8× 214 1.5× 173 1.4× 84 0.9× 9 521

Countries citing papers authored by Yihao Mao

Since Specialization
Citations

This map shows the geographic impact of Yihao Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihao Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihao Mao more than expected).

Fields of papers citing papers by Yihao Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yihao Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihao Mao. The network helps show where Yihao Mao may publish in the future.

Co-authorship network of co-authors of Yihao Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yihao Mao. A scholar is included among the top collaborators of Yihao Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yihao Mao. Yihao Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Siyuan, Li‐Wei Zhou, Xiaofei Wang, et al.. (2025). Antibody-based surface plasmon resonance sensor platform for monitoring amikacin drug concentrations in human serum samples. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 333. 125840–125840.
2.
Xu, Zhou-Geng, Yujie Liu, Long Wang, et al.. (2025). A unified cell atlas of vascular plants reveals cell-type foundational genes and accelerates gene discovery. Cell. 188(22). 6370–6390.e29. 2 indexed citations
3.
Jiang, Chang, Qingyang Feng, Yihao Mao, et al.. (2024). Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer. International Immunopharmacology. 130. 111771–111771. 8 indexed citations
4.
Lv, Yang, Peng Zheng, Yihao Mao, et al.. (2023). Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. Cancer Science. 115(1). 257–269. 7 indexed citations
5.
Xu, Yuqiu, et al.. (2023). B cells in tumor metastasis: friend or foe?. International Journal of Biological Sciences. 19(8). 2382–2393. 12 indexed citations
6.
Tang, Wentao, Yu Liu, Meiling Ji, et al.. (2022). Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases. Annals of Surgical Oncology. 29(6). 3593–3603. 1 indexed citations
7.
Mao, Yihao, Yuqiu Xu, Chang Jiang, et al.. (2022). The immune phenotypes and different immune escape mechanisms in colorectal cancer. Frontiers in Immunology. 13. 968089–968089. 15 indexed citations
8.
Mao, Yihao, Yijiao Chen, Qi Wu, et al.. (2022). No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and Prognosis. Clinical Medicine Insights Oncology. 16. 1363205801–1363205801. 1 indexed citations
9.
Jiang, Chang, Yihao Mao, Yuqiu Xu, et al.. (2022). CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy. Cancers. 14(19). 4646–4646. 3 indexed citations
10.
Xu, Yuqiu, Qingyang Feng, Yijiao Chen, et al.. (2021). Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study. Cancer Management and Research. Volume 13. 1087–1097. 2 indexed citations
11.
Zhang, Zhiyuan, Meiling Ji, Yang Lv, et al.. (2020). A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I–III rectal cancer. Genomics. 112(5). 3274–3283. 9 indexed citations
12.
Zhang, Zhiyuan, Qingyang Feng, Peng Zheng, et al.. (2020). Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer. Genomics. 112(6). 4032–4040. 12 indexed citations
13.
Feng, Qingyang, Yihao Mao, Meiling Ji, et al.. (2020). High MICB expression as a biomarker for good prognosis of colorectal cancer. Journal of Cancer Research and Clinical Oncology. 146(6). 1405–1413. 13 indexed citations
14.
Feng, Qingyang, Wenju Chang, Yihao Mao, et al.. (2019). Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clinical Cancer Research. 25(13). 3896–3907. 104 indexed citations
15.
Ji, Meiling, Wenxiang Li, Guodong He, et al.. (2019). Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway. Journal of Cancer. 10(22). 5557–5566. 18 indexed citations
16.
Lv, Yang, Qingyang Feng, Yihao Mao, et al.. (2019). <p>Exploration of exact significance of lymph node ratio and construction of a novel stage in colon cancer with no distant metastasis</p>. Cancer Management and Research. Volume 11. 6841–6854. 7 indexed citations
17.
18.
Mao, Yihao, Qingyang Feng, Peng Zheng, et al.. (2018). Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer. Cancer Management and Research. Volume 10. 3569–3577. 87 indexed citations
19.
Xu, Jianmin, Qingyang Feng, Wenju Chang, et al.. (2018). Ratio of M2 tumor-associated macrophages as a better prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer.. Journal of Clinical Oncology. 36(15_suppl). e15582–e15582. 1 indexed citations
20.
Mao, Yihao, Hong Liu, Rong Ye, Yonghong Shi, & Zhijian Song. (2014). Detection and segmentation of virus plaque using HOG and SVM: Toward automatic plaque assay. Bio-Medical Materials and Engineering. 24(6). 3187–3198. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Osugi Breakdown of academic impact, for papers by Xiying Shao Breakdown of academic impact, for papers by Teming Zhang Breakdown of academic impact, for papers by Helen Thut Breakdown of academic impact, for papers by Dagui Lin Breakdown of academic impact, for papers by Louqian Zhang Breakdown of academic impact, for papers by Zhengchun Kang Breakdown of academic impact, for papers by Tiepeng Li Breakdown of academic impact, for papers by Zaoke He Breakdown of academic impact, for papers by Nivedita Chowdhury
Rankless by CCL
2026